2023 annual financial data
Enanta Pharmaceuticals 2023 Operating margin
Enanta Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -173.23%.
Operating income was -137,207,000 USD and net income was -133,816,000 USD.
Operating cash flow was -103,154,000 USD.
Get free Enanta Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 79,204,000 USD
- Operating income
- -137,207,000 USD
- Net income
- -133,816,000 USD
- Operating cash flow
- -103,154,000 USD